Strategy & Market Positioning
Strategic roadmaps, competitive landscape analysis, go-to-market strategy, regulatory and reimbursement alignment, portfolio prioritization and market opportunity assessment.
Diagnostics strategy and growth advisory
Strategic advisory for healthcare innovators, diagnostics companies and investors
From strategic positioning to investment readiness and market execution, Space-B Consulting helps breakthrough diagnostic technologies move from scientific promise to sustainable market adoption.
Who we are
Expertise across the full healthcare innovation pathway
Space-B Consulting is an independent healthcare strategy firm based in Toulouse, advising diagnostics and health-tech companies across Europe and internationally.
Our work combines scientific understanding, commercial discipline and senior operational experience across molecular diagnostics, infectious diseases, advanced healthcare technologies and international markets.
30+
years of diagnostics leadership
Global
experience across Europe, Japan, China, Australia, South Korea, the UK and the US
Focused
strategy, partnerships and growth execution
Services
Clear decisions from early development to market execution
Investment & Transaction Advisory
Investment readiness, equity stories, investor materials, M&A advisory, licensing and partnership structuring for venture capital, private equity and strategic investors.
Technology & Risk Assessment
Scientific and technological due diligence, regulatory pathway assessment, market access analysis, differentiation review, commercial feasibility and execution risk evaluation.
Partnerships, Licensing & EU Programs
Partner scouting, contract and negotiation support, technology scouting, international introductions and support for collaborative European programs.
Who we support
Strategic advisory tailored to each stage of growth
Startups
We help founders translate scientific complexity into clear value propositions, credible growth strategies and compelling investment cases.
SMEs
We help growing diagnostics and healthcare companies accelerate market expansion, strengthen positioning and move from analysis to action.
Banks & Investors
We provide independent scientific and strategic evaluation to support informed investment, partnership and transaction decisions.
Core expertise
Deep focus in diagnostics and healthcare technologies
- Molecular diagnostics: PCR, NGS and rapid platforms
- Infectious diseases, sepsis and oncology applications
- IVDR, CE marking, market access and reimbursement strategy
- Licensing, strategic partnerships and international expansion
- M&A advisory, transaction support and due diligence
Leadership
Strategic vision and operational execution
 copy 2 Small.jpeg)
Bruno Bombarde
President
Doctor of Pharmacy and trained biologist with more than three decades of international leadership in medical diagnostics, global strategy, business development, M&A and strategic partnerships.
Caroline Gough
Managing Director
Cambridge graduate with extensive operational leadership experience, focused on translating strategic ambition into structured implementation and sustainable growth.
Philippe Planchon
Associate Consultant
Biological Sciences PhD with more than 30 years of international experience in molecular diagnostics, infectious diseases, and oncology. Proven track record in developing and leading strategic partnerships with global biopharmaceutical and diagnostic companies.
Roger Lau
Senior Advisor, China and Asia-Pacific
Senior diagnostics industry executive with more than 35 years of experience across China and Asia-Pacific. Former Vice President Sales & Marketing for Greater China at bioMerieux, he advises diagnostic and life science companies on market entry, business development and growth strategies in China and Asia.
Contact
You are developing a breakthrough diagnostic technology. Let us ensure it reaches its full potential.
All discussions are treated with strict confidentiality.